ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EVGN Evogene Ltd

0.73
0.0799 (12.29%)
Pre Market
Last Updated: 09:28:10
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Evogene Ltd EVGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0799 12.29% 0.73 09:28:10
Open Price Low Price High Price Close Price Prev Close
0.6501
more quote information »

Recent News

Date Time Source Heading
4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/16/202407:00PRNUSBiomica to Present at the American Society of Clinical..
4/11/202407:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
4/02/202407:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
3/28/202409:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
3/20/202409:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
3/19/202409:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
3/13/202409:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
3/07/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/07/202407:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
3/06/202407:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
3/05/202407:00PRNUSCasterra Announces New Agreements with Seed Producers in..
3/01/202407:03EDGAR2Form F-3 - Registration statement by foreign private issuers
2/28/202407:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
2/26/202407:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
2/22/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/22/202407:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
2/21/202407:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/21/202407:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
2/20/202407:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
2/14/202420:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202407:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
1/23/202407:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
1/17/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/17/202407:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
1/09/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202307:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
12/19/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/19/202307:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
12/05/202307:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
11/28/202307:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
11/15/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/15/202307:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
11/08/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202307:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
10/31/202307:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
10/18/202307:00PRNUSEvogene Provides Operational Update Amidst Current Security..
9/27/202307:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
9/21/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/19/202307:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/13/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/23/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/202307:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
8/15/202307:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
8/08/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202307:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
7/25/202307:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
7/19/202307:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
7/18/202314:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/17/202308:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock